CRISPR-Cas9 Gene Editing: Advances and Applications in Human Therapeutics

• Dr. Anna Müller

  Department of Molecular Biology Heidelberg University Heidelberg, Germany

  Author

CRISPR-Cas9 gene editing has revolutionized molecular biology, offering precise and efficient tools for modifying genomes. Its applications in human therapeutics hold promise for treating genetic disorders, cancer, and infectious diseases. This paper reviews recent advances in CRISPR-Cas9 technology from 2023 to 2025, highlighting its mechanisms, clinical applications, ethical considerations, and challenges in therapeutic use. The study emphasizes the integration of CRISPR-based strategies into personalized medicine and discusses regulatory, safety, and delivery hurdles. The findings underscore the transformative potential of gene editing while acknowledging the need for rigorous clinical validation and ethical governance.

• pdf

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

1. Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.